 He's not alone. Trulicity and similar drugs like Ozempic and Monjaro have all been in short supply over the last 18 months. Rodot Co., a telehealth company, built a free online tool to help patients report shortages of these drugs. That company's CEO, Zach Rotano, said they received 35,000 reports of GLP-1 shortages within two weeks of launching the tool last month.